A comparative and descriptive study of asthma in chronic rhinosinusitis with nasal polyps

American Journal of Rhinology and Allergy

Volumn 28, Issue 5, 2014, Pages 383-387

  Håkansson, Kåre ^a   Thomsen, Simon Francis ^b   Konge, Lars ^b   Mortensen, Jann ^b   Backer, Vibeke ^b   Von Buchwald, Christian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MANNITOL; PREDNISOLONE;

ADULT; AGED; ARTICLE; ASTHMA; ATOPY; BRONCHODILATATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; ENDOSCOPIC SINUS SURGERY; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; NOSE POLYP; PEAK EXPIRATORY FLOW; PRICK TEST; PROSPECTIVE STUDY; QUALITY OF LIFE; SKIN TEST; SPIROMETRY; CHRONIC DISEASE; COMPARATIVE STUDY; COMPLICATION; MIDDLE AGED; PREVALENCE; RHINITIS; SINUSITIS;

ADULT; AGED; ASTHMA; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RHINITIS; SINUSITIS;

EID: 84907912673     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2014.28.4076     Document Type: Article

References (47)

1. Johansson L, Akerlund A, Holmberg K, et al. Prevalence of nasal polyps in adults: The Skövde population-based study. Ann Otol Rhinol Laryngol 112:625-629, 2003.
2. Lange B, Holst R, Thilsing T, et al Quality of life and associated factors in persons with chronic rhinosinusitis in the general population. Clin Otolaryngol 2013. (DOI: 10.1111/coa.12189; Epub ahead of print.
3. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 23:1-298, 2012.
4. Ragab A, Clement P, and Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 18:15-21, 2004.
5. Alobid I, Bentez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: Comparison between the effects of medical and surgical treatments. Allergy 60:452-458, 2005.
6. Bachert C, Zhang N, Holtappels G, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126:962-968, 968.e1-6, 2010.
7. Collins MM, Pang YT, Loughran S, and Wilson JA. Environmental risk factors and gender in nasal polyposis. Clin Otolaryngol Allied Sci 27:314-317, 2002.
8. Hopkins C, Browne JP, Slack R, et al. The Lund-Mackay staging system for chronic rhinosinusitis: How is it used and what does it predict? Otolaryngol Head Neck Surg 137:555-561, 2007.
9. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe. Allergy 67:91-98, 2012.
10. Klossek JM, Neukirch F, Pribil C, et al. Prevalence of nasal polyposis in France: A cross-sectional, case-control study. Allergy 60:233-237, 2005.
11. Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 17:243-249, 1996.
12. Seybt MW, McMains KC, and Kountakis SE. The prevalence and effect of asthma on adults with chronic rhinosinusitis. Ear Nose Throat J 86:409-411, 2007.
13. Small CB, Stryszak P, Danzig M, and Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. J Allergy Clin Immunol 121:928-932, 2008.
14. Williamson PA, Vaidyanathan S, Clearie K, et al. Airway dysfunction in nasal polyposis: A spectrum of asthmatic disease? Clin Exp Allergy 41:1379-1385, 2011.
15. Frenkiel S, Small P, Rochon L, et al. Nasal polyposis-A multidisciplinary study. J Otolaryngol 11:275-278, 1982.
16. Kim HY, So YK, Dhong HJ, et al. Prevalence of lower airway diseases in patients with chronic rhinosinusitis. Acta Otolaryngol Suppl 110-114, 2007.
17. Staikuniene J, Vaitkus S, Japertiene LM, and Ryskiene S. Association of chronic rhinosinusitis with nasal polyps and asthma: Clinical and radiological features, allergy and inflammation markers. Medicina (Kaunas) 44:257-265, 2008.
18. Johansson L, Brämerson A, Holmberg K, et al. Clinical relevance of nasal polyps in individuals recruited from a general populationbased study. Acta Otolaryngol 124:77-81, 2004.
19. Lamblin C, Tillie-Leblond I, Darras J, et al. Sequential evaluation of pulmonary function and bronchial hyperresponsiveness in patients with nasal polyposis: A prospective study. Am J Respir Crit Care Med 155:99-103, 1997.
20. Bonfils P, Avan P, and Malinvaud D. Influence of allergy on the symptoms and treatment of nasal polyposis. Acta Otolaryngol 126: 839-844, 2006.
21. Munoz del Castillo, Jurado-Ramos A, Fernández-Conde BL, et al. Allergenic profile of nasal polyposis. J Investig Allergol Clin Immunol 19:110-116, 2009.
22. Hakansson K, von Buchwald C, Thomsen SF, et al. Nonallergic rhinitis and its association with smoking and lower airway disease: A general population study. Am J Rhinol Allergy 25:25-29, 2011.
23. Hakansson K, Konge L, Thomsen S, et al. Sinonasal inflammation in COPD: A systematic review. Eur Respir J 42:1402-1411, 2013.
24. Suh JD, Cohen NA, and Palmer JN. Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 18:27-31, 2010.
25. Lundberg JO. Nitric oxide and the paranasal sinuses. Anat Rec (Hoboken) 291:1479-1484, 2008.
26. Jani AL, and Hamilos DL. Current thinking on the relationship between rhinosinusitis and asthma. J Asthma 42:1-7, 2005.
27. Scadding G. Nitric oxide in the airways. Curr Opin Otolaryngol Head Neck Surg 15:258-263, 2007.
28. Hellings PW,and Prokopakis EP. Global airway disease beyond allergy. Curr Allergy Asthma Rep 10:143-149, 2010.
29. Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 14:32-38, 1999.
30. Hellquist HB. Nasal polyps update. Histopathology. Allergy Asthma Proc 17:237-242.
31. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 26:511-522, 2005.
32. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the singlebreath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720-735, 2005.
33. Sverrild A, Porsbjerg C, and Backer V. The use of inhaled mannitol in the diagnosis and management of asthma. Expert Opin Pharmacother 13:115-123, 2012.
34. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 62:102-112, 2007.
35. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143-178, 2008.
36. Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-Classification, diagnosis and management: Review of the EAACI/ENDA(#) and GA2LEN/HANNA. Allergy 66:818-829, 2011.
37. Nolte H, Nepper-Christensen S, and Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med 100:354-362, 2006.
38. Sahlstrand-Johnson P, Ohlsson B, Von Buchwald C, et al. A multicentre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology 49:420-428, 2011.
39. Katotomichelakis M, Simopoulos E, Zhang N, et al. Olfactory dysfunction and asthma as risk factors for poor quality of life in upper airway diseases. Am J Rhinol Allergy 27:293-298, 2013.
40. Ceylan E, Gencer M, and San I. Nasal polyps and the severity of asthma. Respirology 12:272-276, 2007.
41. Nonaka M, Tanaka Y, Pawankar R, and Yoshihara T. Orally inhaled fluticasone propionate improved chronic rhinosinusitis with co-morbid asthma: Report of a case. Asian Pac J Allergy Immunol 31:84-87, 2013.
42. Lehmann S, Bakke PS, Eide GE, and Gulsvik A. Bronchodilator response to adrenergic beta2-agonists: Relationship to symptoms in an adult community. Respir Med 101:1183-1190, 2007.
43. Houser SM, and Keen KJ. The role of allergy and smoking in chronic rhinosinusitis and polyposis. Laryngoscope 118:1521-1527, 2008.
44. Settipane GA, and Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6,037 patients. J Allergy Clin Immunol 59:17-21, 1977.
45. Granström G, Jacobsson E, and Jeppsson PH. Influence of allergy, asthma and hypertension on nasal polyposis. Acta Otolaryngol Suppl 492:22-27, 1992.
46. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131:110-116.e1, 2013.
47. Chang JE, White A, Simon RA, and Stevenson DD. Aspirin-exacerbated respiratory disease: Burden of disease. Allergy Asthma Proc 33:117-121, 2012.